DateMarch 27
EventBoard of Directors – Approval of the Draft Financial Statements as at December 31, 2025 and of the Consolidated Financial Statements as at December 31, 2025
DateApril 28
EventShareholders’ Meeting – Approval of the Financial Statements as at December 31, 2025 and presentation of the Consolidated Financial Statements
DateSeptember 28
EventBoard of Directors – Approval of the Consolidated Half-Year Financial Report as at June 30, 2026, voluntarily submitted to a limited audit review